[Effect of riboxine, levamisole and sodium oxybutyrate on the course of experimental tuberculosis].
Aleksandrova
A E
AE
Shcherbakova
N M
NM
Borisova
L E
LE
Zabolotnykh
N V
NV
D000818:Animals; D004353:Drug Evaluation, Preclinical; D004359:Drug Therapy, Combination; D006885:Hydroxybutyrates / Q000627:therapeutic use*; D007109:Immunity / Q000187:drug effects; D007288:Inosine / Q000627:therapeutic use*; D007773:Lactates / Q000097:blood; D007978:Levamisole / Q000627:therapeutic use*; D051379:Mice; D008808:Mice, Inbred CBA; D009163:Mycobacterium bovis; D011773:Pyruvates / Q000097:blood; D011817:Rabbits; D012978:Sodium Oxybate / Q000627:therapeutic use*; D014376:Tuberculosis / Q000097:blood / Q000188:drug therapy* / Q000276:immunology
D006885:Hydroxybutyrates; D007773:Lactates; D011773:Pyruvates; D007978:Levamisole; D007288:Inosine; D012978:Sodium Oxybate
Vliianie riboksina, levamizola i natriia oksibutirata na techenie éksperimental'nogo tuberkuleza.